E Fund Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $756K | Buy |
21,009
+4,013
| +24% | +$144K | 0.04% | 191 |
|
|
2025
Q1 | $670K | Sell |
16,996
-6,558
| -28% | -$259K | 0.03% | 197 |
|
|
2024
Q4 | $709K | Buy |
23,554
+1,711
| +8% | +$51.5K | 0.04% | 187 |
|
|
2024
Q3 | $511K | Buy |
21,843
+1,378
| +7% | +$32.2K | 0.03% | 193 |
|
|
2024
Q2 | $364K | Sell |
20,465
-5,361
| -21% | -$95.4K | 0.02% | 208 |
|
|
2024
Q1 | $393K | Sell |
25,826
-4,727
| -15% | -$71.9K | 0.02% | 226 |
|
|
2023
Q4 | $522K | Sell |
30,553
-13,457
| -31% | -$230K | 0.03% | 154 |
|
|
2023
Q3 | $368K | Buy |
44,010
+27,744
| +171% | +$232K | 0.03% | 181 |
|
|
2023
Q2 | $404K | Sell |
16,266
-11,162
| -41% | -$277K | 0.03% | 164 |
|
|
2023
Q1 | $413K | Sell |
27,428
-11,965
| -30% | -$180K | 0.03% | 155 |
|
|
2022
Q4 | $466K | Sell |
39,393
-13,757
| -26% | -$163K | 0.04% | 141 |
|
|
2022
Q3 | $315K | Sell |
53,150
-16,955
| -24% | -$100K | 0.03% | 229 |
|
|
2022
Q2 | $298K | Buy |
70,105
+39,622
| +130% | +$168K | 0.03% | 235 |
|
|
2022
Q1 | $290K | Buy |
30,483
+20,017
| +191% | +$190K | 0.01% | 205 |
|
|
2021
Q4 | $199K | Buy |
+10,466
| New | +$199K | 0.01% | 265 |
|